Larvol Delta - Immunogenicity-and-Safety-of-AdCLDCoV191-OMI-as-a-Booster-A-COVID19-Preventive-Vaccine-in-Healthy-Volunteers

AdCLD-CoV19-1 OMI - Cellid

Comirnaty (tozinameran) - Pfizer, Fosun Pharma, BioNTech

http://clinicaltrials.gov/ct2/show/NCT05993325

Aug 15, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next